Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Doctors have warned of some hidden and potentially fatal side effects of using Ozempic amid the increasing popularity of the ...

Liraglutide helps promote weight loss by decreasing appetite ... is only approved for treating type 2 diabetes. Wegovy and Ozempic both contain semaglutide, but Wegovy provides a higher dose.

Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are sometimes taken off-label for weight loss. Some pharmacies also ...

Adverse reactions to weight-loss jabs are set to soar by more than 350% in a single year, according to the latest data.

The study showed that Glucagon-like peptide-1 (GLP-1) analogues — drugs developed to treat obesity — likely curb alcohol ...